Demand for Ozempic, Wegovy, Zepbound, and Mounjaro has led to the rise of online companies selling what they claim are cheaper versions of the once-a-week injectable medications. But regulation is ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

A tight supply of Novo's semaglutide and Lilly's tirzepatide - sold as Wegovy and Zepbound, respectively, for weight loss - has fueled demand for compounded versions. Median first-month prices ...

a subscription-based weight-loss company that offers compounded semaglutide. Cook said 1 to 2 million Americans take compounded GLP-1 medications, and the vast majority of those patients are ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

Staci Rice lost 64 pounds on a compounded form of the weight loss drug semaglutide. It was expensive so she tried to maintain her weight loss without the medication, and gained 26 pounds.